Article ID Journal Published Year Pages File Type
6065817 Journal of Allergy and Clinical Immunology 2014 8 Pages PDF
Abstract
This is the first report showing rapid improvement of the AD molecular signature with targeted anti-IL-4 receptor α therapy. These data suggest that IL-4 and IL-13 drive a complex, TH2-centered inflammatory axis in patients with AD.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , , , , , , , , , , , ,